SCHEMBL17547631

SCHEMBL17547631

CCC(C)(C)C(=O)OC12CC3CC(C1)C1(OCC(F)(F)C(F)(F)CO1)C(C3)C2

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1697254 0.86 CYP17A1 (0.35) CYP17A1CYP19A1
SCHEMBL26061830 0.82 CYP17A1 (0.33) CYP17A1CYP19A1
SCHEMBL1697258 0.81 CYP17A1 (0.34) CYP17A1CYP19A1
SCHEMBL14651524 0.81 CYP17A1 (0.30) CYP17A1CYP19A1
SCHEMBL24068236 0.80 CYP17A1 (0.30) CYP17A1CYP19A1
SCHEMBL26544555 0.80 HSD11B1 (0.31) CYP17A1CYP19A1HSD11B1
SCHEMBL1704343 0.80 CYP17A1 (0.30) CYP17A1CYP19A1
SCHEMBL106919 0.80 CYP19A1 (0.46) CYP17A1CYP19A1
SCHEMBL14258838 0.79 CYP19A1 (0.37) CYP17A1CYP19A1HSD11B1
SCHEMBL18253501 0.79 CYP19A1 (0.37) CYP17A1CYP19A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9644056-B2 Compound, resin and photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-09 — — US disclosed
US-9638996-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-02 — — US disclosed
US-20160237190-A1 COMPOUND, RESIN AND PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-08-18 — — US disclosed
US-20160062234-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160237190-A1 COMPOUND, RESIN AND PHOTORESIST COMPOSITION HAX1, F11, RXRA CYP17A1 1537/4885CYP19A1 263/4885HSD11B1 780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback